Microsoft Stock Forecast: Why On-Premise Office 2019 Is Still Important For Microsoft

motek 1The article was written by Motek Moyen Research Seeking Alpha’s #1 Writer on Long Ideas and #2 in Technology – Senior Analyst at I Know First.

Summary:

  • I will upgrade my Office 2016 to the new 2019 version once Microsoft launches the home version. Office 2019 is currently only available for business users.
  • There are hundreds of millions like me who prefer the offline version of Microsoft’s productivity suite.
  • Microsoft will keep on updating its on premise Office suite because Office 365 is not going to reach 300 million active users anytime soon.
  • As of October 2018, there are only more than 135 million active commercial users of Office 365. This is in spite of its platform-agnostic design.
  • Businesses and ordinary Office users who do not rely too much on online collaboration will find it smarter to just a perpetual license for Office 2019.
  • QCOM stock forecastRead The Full Premium Article

    Subscribe to receive exclusive PREMIUM content Here

I Know First Live forecast evaluation: Extensive Portfolio Evaluation Using Stock Picking Based On S&P 500 Universe

Top S&P 500 Stocks

S&P 500 Evaluation Report

In this report we will evaluate the performance of the forecasts generated by the I Know First AI Algorithm for the S&P 500 universe sent to our customers on a daily basis. We will start with an introduction to our stock picking and benchmarking methods and then apply it to the stocks in the S&P500 universe.

Read The Evaluation Report

GOOGL Forecast: Alphabet Focuses on Future Growth and so Should Investors

 

This article was written by Grant Goldstein, a Financial Analyst at I Know First

   

Highlights:

  • Q1 Expenses Worry Stockholders
  • Google's Upcoming Product Line
  • GOOGL Bullish Forecast
I Know First.  

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

Twitter Stock Forecast: Social Media Star Rallies As It Enters S&P 500

  This article was written by Julia Masch, a Financial Analyst at I Know First.




  Highlights

  • Profiting From Profit
  • World Cup and New News Win Engagement
  • Current I Know First Bullish Forecast for TWTR

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

Winning AVXL Stock Forecast: Life Changing Treatment Discoveries and M&A Expectations Add Value to Avanex

“We are looking forward, focusing on executing clinical trials using the inclusion of advanced genomic biomarkers into late-stage CNS precision medicine trials, including our Rett syndrome, Alzheimer’s disease and Parkinson’s disease dementia trials – all indications with high unmet need”

-Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex.

Anavex Life Sciences Corp. (NASDAQ: AVXL) is a biopharmaceutical company focused on using genetic medicine to treat neurodegenerative and neurodevelopmental diseases, such as Alzheimer’s disease

Read More

I Know First Review Weekly Algorithmic Performance: April 23, 2017

I Know First Review

On April 23, 2017, our weekly newsletter was sent out to all I Know First subscribers, which can be found here. Below, you may find the I Know First Review, highlighting the algorithm’s performance for this past week. https://iknowfirst.com/i-know-first-review-weekly-algorithmic-performance-april-23-2017

I Know First Review Weekly Algorithmic Performance: February 19th, 2017

I Know First Review

On February 19, 2017, our weekly newsletter was sent out to all our I Know First subscribers, which can be found here. Below, find the I Know First Review, highlighting the algorithm’s performance for this past week. I Know First Review

Read The Full Review

Quick Win By the Algorithm: PLX is on its way